Isradipine
Active substance: isradipine
CAPSULE · ISRADIPINE 2.5 mg/1
United StatesActive
Marketing holder: Elite Laboratories, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ISRADIPINE · 2.5 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-fd22-7235-b10e-a19c63ab34be,01a1208e-06b5-76ef-90a4-9c73398d354d,01a12094-2ffc-7a28-a024-0513bcc7830d,01a1209a-e1c6-7055-933e-ce1aa9dcb40c,01a1209d-de66-77d9-8fe4-3aa4313ebec0;count=5 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 64850-910
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 64850-910 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 64850-910 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 64850-910 · Verified 2026-10-09 · open in source